Merck & Co., Inc. Holdings & Portfolio - 13F Filings Analysis - Stocknear

Merck & Co., Inc.

CIK Number: 0000310158

215.6M
Market Value
11
# of Holdings
2 months
Avg. Holding Period
Win Rate
Peformance 3-Years

Filing Date: May 14, 2025

Rank Symbol Name Price % Change Shares % Change Shares Market Value Avg. Price Paid % Weight Asset Type
1 MRNA Moderna, Inc.
25.39
+4.44% 2.31M 0.00% 65.44M 41.58 39.83% Share
2 PSNL Personalis, Inc...
6.10
+13.17% 14.04M 0.00% 49.3M 5.78 30.01% Share
3 KYMR Kymera Therapeu...
46.20
+6.26% 772.16K 0.00% 21.13M 40.23 12.86% Share
4 TRDA Entrada Therape...
5.33
+2.11% 1.74M 0.00% 15.73M 17.29 9.57% Share
5 ALEC Alector, Inc.
2.87
+1.06% 3.55M 0.00% 4.36M 1.89 2.65% Share
6 EVAX Evaxion Biotech...
2.88
+2.13% 1.21M +123.89% 2.25M 1.4 1.37% Share
7 STRO Sutro Biopharma...
1.00
+9.49% 2.72M 0.00% 1.77M 1.84 1.08% Share
8 LVTX LAVA Therapeuti...
1.54
-1.6% 1.15M 0.00% 1.46M 0.951 0.89% Share
9 VRDN Viridian Therap...
19.65
-0.86% 93.41K 0.00% 1.26M 19.17 0.77% Share
10 XLO Xilio Therapeut...
0.73
-1.55% 1.48M 0.00% 1.07M 0.955 0.65% Share
11 NEUP Neuphoria Thera...
13.99
+0.50% 10.03K 0.00% 57.76K 3.43 0.04% Share